Related Experiment Video
Updated: May 8, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication
Yasuhiko Yamamoto1, Hiroshi Yamamoto
1Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences , Kanazawa , Japan.
Obesity triggers inflammation and type 2 diabetes via the receptor for advanced glycation end-products (RAGE). RAGE activation in immune cells and adipocytes promotes insulin resistance and diabetic complications.
Area of Science:
- Immunology
- Metabolic Disease Research
- Cellular Biology
Background:
- Obesity is linked to chronic inflammation and type 2 diabetes.
- The innate immune system, involving cells like macrophages and pattern-recognition receptors (PRRs), drives inflammatory responses.
- The receptor for advanced glycation end-products (RAGE) is a key PRR involved in mediating inflammatory danger signals.
Purpose of the Study:
- To investigate the role of RAGE in obesity-associated inflammation and insulin resistance.
- To explore the implications of RAGE expression in adipocytes and immune cells.
- To understand RAGE's contribution to type 2 diabetes and its vascular complications.
Main Methods:
- Analysis of RAGE expression in relevant cell types (adipocytes, immune cells, endothelial cells, pancreatic β cells).
- Investigating the association between RAGE signaling and adipocyte hypertrophy.
- Examining the link between RAGE activity, inflammation, and insulin resistance.
Main Results:
- RAGE expression is found in adipocytes, immune cells, endothelial cells, and pancreatic β cells.
- RAGE is implicated in promoting adipocyte hypertrophy and insulin resistance.
- RAGE-mediated inflammation and adiposity are linked to type 2 diabetes.
Conclusions:
- RAGE acts as a proinflammatory mediator in obesity.
- RAGE signaling contributes to insulin resistance and the development of type 2 diabetes.
- Targeting RAGE may offer therapeutic potential for obesity-related metabolic disorders and diabetic vascular complications.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Diabetic Retinopathy
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
